I really don't want to be a doctor

Chapter 510 FDA Clearance
After Luo Xin left, Jing Xiaoran suddenly thought of Hong Sheng.

Hong Sheng has left Huaxia to study in the United States and started his new journey.

Thinking about it carefully, Shenzhou Lab has cultivated many talents, such as Wang Tuo who has gone to study for a Ph. D., Hong Sheng and Luo Xin now, and a group of other people who left from Shenzhou.

These people have been nurtured by the Shenzhou Laboratory and have grown into a new generation of scientific research talents.

And the name of Shenzhou Laboratory will become more brilliant because of their outstanding performance.

This is a process of mutual achievement.

……

While waiting for news from Pfizer, Jing Xiaoran also received a request for help from Guinea, Africa.

The news came from Director He Mei.

The main reason is that the African medical team encountered difficulties in the issue of the Ebola vaccine, which resulted in no progress in their research and development for a full three months!

Director He Mei in Africa was very anxious.

With Academician Xu Li's acquiescence, they had no choice but to ask Jing Xiaoran for help!

After all, Jing Xiaoran was in charge of this project from the very beginning.

After Jing Xiaoran received the request for help from Africa, he simply replied with one line.

"Short of talent and learning, please find another expert."

They all proposed themselves to the project R&D team, and now they are turning back?

Jing Xiaoran doesn't have this kind of masochistic tendency!

What's more, now Xu Li has stumbled on the GCP review of immune checkpoint inhibitors.

It is even more impossible for him to help the medical aid team in Africa, the team represented by "Xu Li".

And from a scientific research point of view, Jing Xiaoran has already put out all the things he knows.

Even the current Jing Xiaoran cannot solve the problem raised by Director He Mei!
After being rejected by Jing Xiaoran, the medical aid team to Africa was in despair. Director He Mei and others fell into endless predicament and could not extricate themselves.

As for Xu Li, he didn't think so!
In his mind, Shenzhou Lab's immune checkpoint inhibitor GCP project has been blocked.

If he wants to let go of the restrictions, Jing Xiaoran has to help Director He Mei who is far away in Africa to help them solve the problem of Ebola vaccine.

In this way, Xu Li may be able to open the net and abandon the restrictions on immune checkpoint inhibitors.

But in Jing Xiaoran's plan, he never compromised with Xu Li!

"He actually refused?!"

After listening to He Mei's report in Africa, Xu Li frowned like a rope.

I really don't know what is good or bad!
Without his approval, the GCP committee will never pass the review of immune checkpoint inhibitors!

"Then let's see, who will have the last laugh!" Xu Li snorted coldly.

He went on to issue a circular to the GCP committee temporarily prohibiting the review of immune checkpoint inhibitors.

……

On weekends, the Jing family gets together.

Since moving out alone, they can only eat together on weekends.

Mother Jing seized this opportunity and cooked another table full of delicacies.

"Xiao Jin, eat more." Mother Jing looked at Weng Huijin kindly, "Come and eat a piece of lean meat."

Weng Huijin smiled and held out the bowl in front of Mother Jing.

"Thank you auntie."

"You're welcome, you must eat more, you must be very tired after running outside recently."

"good."

After Weng Huijin resigned, she worked in Jing Xiaoran's pharmaceutical factory.

Busy up and down every day, although it is a bit hard, but the results are obvious.

The production line of the pharmaceutical factory has been completed and can be put into production at any time.

While Jing Xiaoran's family was eating happily, he received a trans-oceanic call from the other side of the ocean.

The caller was Hamer from Pfizer.

"Jing, it worked!"

Hamer's joyful voice came from the phone again.

"We are certified by the US FDA!"

Jing Xiaoran was taken aback for a moment, and then immediately became ecstatic.

"You heard me right! We have passed the FDA certification! According to relevant regulations, after obtaining the batch number, the drug can be put into the production line at any time!"

After Pfizer passed the FDA certification, Hammer told Jing Xiaoran the news immediately.

"Mr. Hammer, please send it through the FDA's paper document." Jing Xiaoran said.

"No problem." Hammer said, "As for the propaganda work on the US side, don't worry, Pfizer is solely responsible for it!"

The Jing family members who were eating at the side could clearly feel Jing Xiaoran's happiness.

Everyone didn't dare to show their anger, for fear of disturbing Jing Xiaoran's phone call.

"Mr. Hammer, our finished medicine will be sent to the United States as soon as possible."

"Jing, I will wait for your words! Now many patients are waiting to use immune checkpoint inhibitors, you must be as soon as possible!"

……

After hanging up the phone, Jing Xiaoran's excitement became more intense.

This is the first time in four years that he feels relieved!

But the revolution has not yet succeeded, comrades still need to work hard!
At present, it has only passed the FDA review. If it wants to gain a foothold in China, it still needs to wait for the GCP review results!
……

Since Pfizer announced that Shenzhou Laboratory's immune checkpoint inhibitors have passed FDA review, a major earthquake has occurred in the medical circles of the United States and even the global medical circles.

The first to bear the brunt is AstraZeneca!
When it was learned that Pfizer had obtained the agency rights of immune checkpoint inhibitors from Shenzhou Laboratories and successfully passed the FDA certification, the entire immune checkpoint inhibitor experimental team of AstraZeneca was shocked!
In their proud impression, they represent the best level in the world, especially in the field of immune checkpoint inhibitors, no one will surpass them at all!

But now, reality hit them hard in the face!
A Chinese biopharmaceutical company, as the world's first laboratory, took the lead in launching an immune checkpoint inhibitor!
And their own immune checkpoint inhibitors are still under development!

Now all the eyes of the world are focused on the immune checkpoint inhibitors of Shenzhou Laboratory.

Even if AstraZeneca has successfully developed immune checkpoint inhibitors in the future, its influence has been greatly reduced!

(End of this chapter)